Press release
Tadalafil Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029
In September 2021, IntelGenx Corp. announced that Aquestive Therapeutics, Inc., its co-development and commercialization partner for Tadalafil oral films for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), has signed a definitive license and supply agreement. Securing this commercial relationship is a critical milestone in creative collaboration with Aquestive, and it represents yet another big step toward realising the shared objective of making Tadalafil oral films available to men suffering from ED and BP. In February 2019, Teva Pharmaceutical Industries Ltd. announced the launch of ALYQ in the US, a generic version of ADCIRCA (tadalafil) tablets, 20 mg. ALYQ is a phosphodiesterase 5 (PDE5) inhibitor used to improve exercise performance in people with pulmonary arterial hypertension (PAH). High blood pressure in the lungs' blood arteries is known as PAH. Teva has the largest portfolio of FDA-approved generic pharmaceuticals on the market, with over 550 generic medications accessible, and is the market leader in first-to-file opportunities, with over 100 pending first-to-files in the US. Teva generics are being used to satisfy one out of every seven generic prescriptions written in the US. In the US, ADCIRCA generated roughly $490 million in annual sales in November 2018.
To Request a Sample of our Report on Tadalafil Market: https://www.omrglobal.com/request-sample/tadalafil-market
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
Segment Covered-
By Product
By Application
Regions covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
Competitive Landscape: Glenmark Pharmaceuticals Ltd., Eli, Lilly & Co., and Teva Pharmaceutical Industries Ltd., among others.
Tadalafil Market Report by Segment
By Type
• Purity:98%
• Purity: >98%
By Application
• Erectile Dysfunction
• Benign Prostatic Hyperplasia
• Others
A full Report of Tadalafil Market is Available @ https://www.omrglobal.com/industry-reports/tadalafil-market
Tadalafil Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tadalafil Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029 here
News-ID: 3284402 • Views: …
More Releases from Orion Market Research
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033.
Digital Innovation in Insurance Market Overview
The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are…
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033.
Cigarette Rolling Paper Market Overview
The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers…
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033.
Back Glue Market Overview
The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive…
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033.
Autopilot Systems Market Overview
The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These…
More Releases for Tadalafil
Pharmaceutical Grade Tadalafil Market Set for Steady Growth with Healthcare and …
New Jersey, US State: "The global Pharmaceutical Grade Tadalafil market in the Healthcare and Pharmaceuticals category is projected to reach USD 2.5 billion by 2031, growing at a CAGR of 9.5% from 2025 to 2031. With rising industrial adoption and continuous innovation in Healthcare and Pharmaceuticals applications, the market is estimated to hit USD 1.2 billion in 2024, highlighting strong growth potential throughout the forecast period."
Pharmaceutical Grade Tadalafil Market Size…
Tadalafil Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
"Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Expected Tadalafil Market Size During the Forecast Period?
The expansion of the tadalafil market has been swift in the past few years. Its size is expected to increase from $4.92 billion in 2024 to $5.55 billion in 2025, with a compound annual growth rate (CAGR) of 12.83%. The previously observed growth…
Raksht Pharmaceuticals Tadalafil Market size expansion of Several Folds by 2032
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Tadalafil (Raksht Pharmaceuticals) providing insights into the drug market landscape and market forecast of Tadalafil upto 2032. The report, titled "Tadalafil Market Size, Forecast, and Drug Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market size of Tadalafil in 2032? Tadalafil Market…
Future Scope of Tadalafil Oral Market Expects to See Significant Growth During 2 …
Tadalafil Oral Market 2023 is expected to experience robust growth, offering market players a profitable opportunity to expand their presence in acknowledging economies and increase their revenue streams. To strengthen their position and enhance their market share, companies can leverage this growth potential. To conduct a thorough analysis of the global Tadalafil Oral Market, several crucial factors were considered, including segmentation analysis, current trends, potential future opportunities, growth prospects, and…
Tadalafil API Market Growth Drivers, Trends, Opportunities, Scale and Segment Fo …
LOS ANGELES, United States: The global Tadalafil API market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Tadalafil API market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and…
Tadalafil Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global tadalafil market is expected to grow at a significant CAGR during the forecast period (2021-2027). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches, to remain competitive in the marketplace. For instance, in December 2020, Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global pharmaceutical company, received final…
